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ABSTRACT
Motivation: Viruses employ various means to evade immune
detection. One common evasion strategy is the removal of CD8+
cytotoxic T-lymphocyte epitopes. We here use a combination of
multiple bioinformatic tools and large amount of genomic data to
compute the epitope repertoire presented by over 1300 viruses in
many HLA alleles. We deﬁne the ‘Size of Immune Repertoire score’,
which represents the ratio between the epitope density within a
protein and the expected density. This score is used to study viral
immune evasion.
Results: We show that viral proteins in general have a higher
epitope density than human proteins. This difference is due to a
good ﬁt of the human MHC molecules to the typical amino-acid
usage of viruses. Among different viruses, viruses infecting humans
present less epitopes than non-human viruses. This selection is not
at the amino-acid usage level, but through the removal of speciﬁc
epitopes. Within a single virus, not all proteins express the same
epitopes density. Proteins expressed early in the viral life cycle have
a lower epitope density than late proteins. Such a difference is not
observed in non-human viruses. The removal of early epitopes and
the targeting of the cellular immune response to late viral proteins,
allow the virus a time interval to propagate before its host cells are
destroyed by T cells.
Contact: louzouy@math.biu.ac.il
1 INTRODUCTION
The infection of a cell by a virus can elicit a Cytotoxic T
Lymphocyte(CTL)responsetoviralpeptidespresentedbytheMajor
HistocompatibilityComplex(MHC)classImolecules(Ambagalaet
al., 2005; Gulzar and Copeland, 2004). Such a CTL response plays
a critical role in the host’s anti-viral immune response (McMichael
et al., 1983). This role is suggested by studies indicating a drop of
viral loads and the relief of the acute infection symptoms following
the emergence of virus-speciﬁc CTLs (Borrow et al., 1994), as well
as by data from CD8+Tcells-depleted animal models (Letvin et al.,
1999; Negri et al., 2006). The CTL response is also associated with
a rapid selection of viral CTL escape variants (Howley et al., 2001;
Lichterfeld et al., 2005).
In order to explore the anti-viral CD8+ T cells response, one
has to consider the factors affecting the CTL response, such as
the kinetics of the viral protein expression, the Human Leukocyte
Antigen(HLA)classIgeneticbackgroundoftheinfectedindividuals
and the viral gene diversiﬁcations (Lichterfeld et al., 2005). These
∗To whom correspondence should be addressed.
viralgenesdeterminetheepitoperepertoirepresentedtotheimmune
system and consequently the immune response.
We here propose to use an immunomic methodology combining
genomic data and multiple bioinformatic tools to study the anti-viral
CTL response. Using this immunomic analysis, we present a novel
all-virus analysis of the viral epitope repertoire and highlight the
selective forces affecting viruses and their human host.
In general, CTL epitopes originate from short peptides cleaved
by the proteasome (Rock et al., 2002) that can pass through the
Transporter associated withAntigen Processing (TAP) and associate
non-covalently with the groove of MHC-I molecules. The vast
majority of these epitopes are nine-mers (although octamers and
decamers and even longer epitopes can be observed). A cleaved
nine-mer is presented on an MHC-I molecule only if its afﬁnity to
the MHC molecule is sufﬁciently high. We have recently developed
and improved a set of bioinformatic tools to estimate all peptides
within a virus that can be presented to the immune system (the CTL
epitope repertoire). We here apply this methodology to over 1300
fully sequenced viruses and show that viruses selectively alter their
epitope repertoire.
The HLA locus is the most polymorphic locus in the human
genome. In the class I locus HLA-A, B and C have over 697,
1109 and 381 alleles, respectively (Robinson et al., 2003). This
large polymorphism permits a rapid selection of alleles that can
respond to viral threats. On the other hand, viruses can mutate
rapidly.Forexample,theHIVmutationrateisapproximately1.e–3–
1.e–4 mutations per base pair per division (Cofﬁn, 1995), which is
approximately one mutation per division for the entire viral genome.
This high mutation rate coupled with a short viral life cycle [24–72h
for most viruses (Howley, et al., 2001)] allows viruses to modify
their epitope repertoire within a short time.
Thus, the number of viral epitope is affected by two opposing
trends: the attempts of the human immune system to recognize
virally infected cells and the viral attempts to survive for a long
enough time in the infected cell to bud. We here propose a direct
measure of the epitope number over all fully sequenced viruses to
explore the effect of these opposing forces.
2 METHODS
2.1 Genomic data
Viral and human protein sequences were used for this analysis. The human
sequenceswereobtainedfromtheEnsembldatabase(Birneyetal.,2004).All
human predicted protein-coding regions were used. In the current analysis,
we ignored the effect of point mutations. The viral sequences were obtained
from the NCBI (http://www.ncbi.nlm.nih.gov/) and LANL (Kuiken et al.,
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2003)databases.Theproteinsofsomeofthehumanvirusesweredividedinto
groups, according to the available data. Viruses were classiﬁed into human
or non-human viruses, based on their main host. A virus mainly infecting
non-humans that can infect humans, but is not usually transferred from one
human to the other was classiﬁed as non-human.
2.2 SIR score
Wehaveanalyzedtheratiobetweenthenumberofepitopespresentedinviral
genesandtheirrandomcounterpart.Theepitopenumberwascomputedusing
three algorithms: a homemade cleavage algorithm (Ginodi et al., 2008), a
TAP-binding algorithms developed by Peters et al. (2003) and the BIMAS
MHC binding (Parker et al., 1994) algorithms. We have computed epitopes
for 31 common HLA alleles and weighted the results according to the allele
frequency in the global human population. The algorithms’ quality was
systematically validated versus epitope databases and was found to induce
low FP and FN error rates. A detailed description of the algorithm, their
validationandtheSIRscorecanbefoundinpreviousworks(e.g.Vider-Shalit
et al., 2007).
2.3 Validation
To validate our results, we checked the score of peptides present in
seven different databases: IEDB (Peters et al., 2005), SYFPEITHI
(Rammensee et al., 1999)—www.syfpeithi.de, MHCBN (Bhasin et al.,
2003)—http://www.imtech.res.in/raghava/mhcbn/, MPID (Govindarajan
et al., 2003)—surya.bic.nus.edu.sg/mpid/, MHCPEP (Brusic et al.,
1998)—http://www3.oup.co.uk/nar/database/, AntiJen (Blythe et al., 2002;
McSparronetal.,2003)—http://www.jenner.ac.uk/AntiJen/andHLALigand
(Sathiamurthy et al., 2003)—http://hlaligand.ouhsc.edu/LigandDB.
Assuming that most peptides in the various databases are correct, we
computed the threshold that would maximize the number of presented
peptides from the positive databases, and minimize the number of peptides
in a neutral set of 1 000 000 random peptides with the NCBI database
amino-acid distribution (http://prowl.rockefeller.edu/aainfo/contents.htm).
We have checked for each HLA allele the level of type-I and type-II errors
and attempted to ﬁnd a cutoff minimizing both. For most alleles we found
cutoffs reducing both errors to less than 10% (i.e. 90% inclusion of the
presented peptides and 90% exclusion of the random peptides).
2.4 Statistical analysis
The SIR score of various populations was compared. A one-way t-test with
unknownandunequalvariancewasusedtocomparetheSIRscoresofviruses
in human and non-human hosts, as well as the SIR scores of human and
viral proteins. When comparing viruses, the full virus score was used. When
comparing proteins, the SIR score of each protein was used.At-test over all
alleles was used to compare the average SIR score of the epitopes produced
from the Hidden Markov Models (HMM) based on either human or viral
amino-acid distribution properties. When comparing the early versus late
proteins in a large group of viruses an ANOVA procedure was used. In the
HIV analysis, we ﬁrst performed an average over all sequences of each
protein, and then compared the average SIR score of all proteins among
different organisms. The ﬁrst averaging was required since the sequence
number in different HIV signiﬁcantly varies.
3 RESULTS
3.1 SIR score
In order to study the human immune response to the viral epitope
repertoire, we computed all predicted epitopes in each viral protein
inover1300viruses.PredictedCTLepitopesarenine-mersfulﬁlling
three criteria: (i) production through proteasomal cleavage. In other
words, a given peptide can be potentially presented if its extreme
Fig. 1. Algorithm for the SIR score computation. Each viral gene is divided
intoallnine-mersandtheappropriateﬂankingregions(a).Foreachnine-mer
a cleavage score is computed (b). We compute a TAP binding for all nine-
merswithapositivecleavagescoreandchooseonlysupra-thresholdpeptides
(c). The MHC-binding score of all TAP-binding and cleaved nine-mers is
computed (d). Nine-mers passing all these stages are deﬁned as epitopes.
We then compute the number of epitopes per protein per HLA allele (e).
and ﬂanking residues enhance proteasomal cleavage and if it is not
cleaved in its center (Ginodi et al., 2008). (ii) transport through the
TAPmachinerytotheendoplasmicreticulum(ER).(iii)presentation
in the context of MHC-I (Fig. 1). We have used three algorithms to
predict all peptides within a protein successfully passing all these
stages (Louzoun and Vider, 2004; Peters et al., 2003; Parker et al.,
1994). Speciﬁcally, each viral gene was divided into all nine-mers
and the appropriate ﬂanking regions. For each nine-mer a cleavage
score is computed, based on the nine-mer itself and its ﬂanking
regions. Only peptides computed to be properly cut were taken to
the next stage. We then computed a TAP-binding score for all nine-
mers with a positive cleavage score and choose only supra-threshold
peptides. The last stage of the analysis is based on allele-speciﬁc
MHC-binding scores of all TAP-binding and cleaved nine-mers.
Resulting nine-mers that bind a given MHC molecule are deﬁned
as epitopes for this HLA allele. All algorithms used here were
validated using a quality assurance process versus seven different
databases of epitopes experimentally measured to be presented. The
validation process ensured that the error levels are low enough to
allow a systematic analysis of the repertoire (Ginodi, et al., 2008)
(http://peptibase.cs.biu.ac.il/peptibase/validation.htm).
A fraction of the epitopes is transported through a TAP-
independent pathway (Yewdell et al., 1998). Since we performed
a comparative analysis, we ignored this fraction, assuming that their
statistics resemble those of TAP-dependent epitopes and that they
should have only a minor effect on the total epitope number. We
have ignored octamers and decamers for the same reasons. We
estimated the number of epitopes from viral proteins on 9 HLA-
A, 19 HLA-B and 3 HLA-C alleles most common in the global
human population. These alleles have well-deﬁned MHC-binding
motifs. These combined HLA alleles are present in 80–90% of the
human population.
3.2 Human vs viral epitope density
In order to check if the MHC allele distribution has evolved to
maximizethepresentationofviralepitopes,wemeasuredtheepitope
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Fig. 2. Comparison of epitope density in human and viral proteins. The
white bars represent the ratio between the relative change between the viral
andhumanepitopedensities(i.e.viralepitopedesnity/humanepitopedensity
–1). All positive values represent a higher viral epitope density. The black
bars represent the same comparison performed on a random sequence based
on human and viral amino-acid distributions.
density of human and viral proteins and compared them in the same
allele. The epitope density of a sequence is deﬁned as the number of
predicted epitopes divided by the number of candidate nine-mers.
Indeedsystematically,viralproteinsexpressmoreepitopesthantheir
human counterpart over the vast majority of alleles (Fig. 2, empty
bars) (P< 1.e–7).
We further checked the evolutionary selection of HLA alleles by
comparingthefrequencyoftheHLAallelesandtheratiobetweenthe
density of human and viral epitopes in the same allele. The alleles
with the highest ratio are the most frequent one (20% increased
frequency of alleles with high ratio compared with alleles with low
ratio) highlighting a possible selection at the population level of
alleles presenting a large number of viral epitopes.
The most natural mechanism for such a selection is that alleles-
binding residues over-represented in viral sequences are preferred.
In order to test this hypothesis, we produced two random sequences
with different amino-acid distributions. We trained two distinct
Markov models on all human and all viral proteins, respectively and
produced very long random sequences (1.e6 amino acids) based on
these models. We then compared the epitope densities of these two
random sequences in each HLA allele (Fig. 2). The ratio between
the epitope density of the random sequence based on viral amino
acids and the random sequence based on human amino acid is even
larger than the ratio between the real viral and human proteins
epitope densities (Fig. 2) (P< 0.02 t-test on the ratio between
epitopes from the viral and human Markov models, compared with
the ratio between computed epitopes from the viral and human
real protein sequences). The difference between the Markov models
shows that the human MHC system is evolving to recognize the
viralamino-aciddistribution.Thesmallerdifferencebetweenhuman
and viral epitope numbers shows that within the broad speciﬁcity
of human MHC to preferentially bind epitopes with viral amino-
acid distribution, viruses speciﬁcally mutate their epitopes to limit
detection.
Table 1. SIR score of human and non-human viruses used in analysis
Virus SIR Virus SIR
Human herpes virus 1 0.89 HIV-1 0.71
Human herpes virus 4 0.91 HIV-2 0.73
Human herpes virus 5-AD169 0.87 SIVcpz 0.79
Human herpes virus 5-Merlin 0.87 SIVmac 0.79
Human herpesvirus 8 0.92 SIVsm 0.87
Ostreid herpes virus 1 1.08
Ictalurid herpes virus 1 1.01 HBV A 0.82
Gallid herpes virus 1 1.00 HBV B 0.92
Alcelaphine herpes virus 1 1.00 HBV C 0.88
Meleagrid herpes virus 1 0.98 HBV D 0.85
Equid herpes virus 1 0.94 HBV E 0.82
Psittacid herpes virus 1 0.91 HBV F 0.90
Suid herpes virus 1 0.91 HBV G 0.91
Murid herpes virus 1 0.91 HBV H 0.83
Bovine herpes virus 1 0.90 gsHBV 1.03
Cercopithecine herpes virus 1 0.87 WHV 1.20
Tupaiid herpes virus 1 0.86 DHBV 1.03
Bovine herpes virus 4 1.06 gooseHBV 0.98
Equid herpes virus 4 0.96 heronHBV 0.94
Murid herpes virus 4 0.95
Pongine herpes virus 4 0.86
Bovine herpes virus 5 0.90
Cercopithecine herpes virus 8 0.92
3.3 Human and non-human hosts
Among viruses, the attempts to mutate epitopes should only be
observed in human viruses (viruses infecting a human host). We
compared the epitope density in viruses living in a human host
and the epitope density in their non-human counterparts. In order
to ease the comparison, we used the number of epitopes in the
Markov-Model-based random strand produced from all viral protein
as a normalization factor. We deﬁned a score representing the ratio
between the epitope density in a given protein and the epitope
density in the viral random strand and named it the ‘Size of Immune
Repertoire’ (SIR) score (Almani et al., 2008; Vider-Shalit et al.,
2007). This score can be interpreted as the ratio of the number of
predicted CTL epitopes to the number of epitopes expected within
the same number of random nine-mers with similar amino acid
and amino-acid couples frequency distribution (Vider-Shalit et al.,
2007). For example, assume a 308-amino acid long sequence. Such
a sequence has 300 overlapping nine-mers. If a set of 300 random
nine-mers with a similar amino-acid distribution is expected to have
10 HLA A*0201 epitopes and the sequence is computed to have
4 HLA A*0201 epitopes, the SIR score of the sequence for HLA
A*0201 would be 0.4. The SIR score of a gene in a population is
deﬁned as the average SIR score over all HLAs, weighted by the
HLA frequencies in this population. An average SIR score of <1
represents an under-presentation of epitopes, while an average SIR
score of >1 actually represents an over-presentation of epitopes.
Inordertocomparevirusesfromhumanandnonhumanhosts, we
used three groups of viruses from different families. We compared
the SIR scores of human herpes viruses and the ones of non-human
herpes viruses. Five human and 18 non-human Herpes strains were
tested on human MHC alleles (Vider-Shalit et al., 2007; Table 1,
Fig. 3a). The average SIR score of the human herpes viruses was
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Fig. 3. The average SIR score of human versus non-human viruses. Data are shown for three viruses: Herpes virus (HHV-1, HHV-4, HHV-5 and HHV-8), (a)
HIV (HIV-1 and HIV-2) (b) and Hepatitis B (strains A-H) virus. (c) The black columns represent human strains while the gray columns represent non-human
strains. In most cases, the average SIR score of the human viruses are lower than the non-human viruses. The lower right drawing represents the SIR score
distributions of all full sequenced viruses from the NCBI. (d) In general, the SIR score of the non-human viruses (gray dashed line) was distributed around 1
while the human viruses (black thick line) was <1.
lowerthantheirnon-humancounterparts(t-testP<0.003).Asimilar
result can be observed when comparing Human immunodeﬁciency
virus (HIV) I and II, with the respective Simian immunodeﬁciency
virus (SIV) that originated them (Vider-Shalit et al., 2008; P<0.02).
We computed the SIR score of all HIV-1, HIV-2, SIVcpz, SIVsm
and SIVmac sequences in the LANL and NCBI databases (Kuiken
et al., 2003). The SIVcpz, which is the ancestor of HIV-1, has a
higher SIR score than average SIR score of all HIV-1 sequences.
The SIR score of HIV-2 is also smaller than the SIR scores of SIVsm
and SIVmac that originated it (Vider-Shalit et al., 2008) (Fig. 3b).
Another virus with human strains as well as strains infecting other
species is Hepatitis B virus (HBV). Viruses similar to HBV exist
among others in ducks and squirrels (Table 1). As was the case for
theHerpesandtheHIV,theSIRscoreofnon-humanhepatitisviruses
is ∼1, while the SIR score of the HBVis lower than 1 (Fig. 3c;T-test
P<0.01). In the case of HBV, this comparison holds at the single
protein level, for most proteins. Most HBV proteins have a lower
SIR score than their non-human counterpart (X is only compared to
mammalian Hepadnaviruses).
More generally, when comparing the SIR scores of all human-
infecting viruses, it is signiﬁcantly lower than the one of non-human
viruses [Fig. 3d; (t-test P< 1.e–7)]. However, this last result should
be taken with a grain of salt, since the SIR score of different virus
families can signiﬁcantly vary. Thus, the average over multiple
families is affected by the number of available fully sequenced
viruses in each family. The Human Papillomavirus (HPV) family
(Papillomaviridae) is one of the most highly sequenced human viral
families. HPV have a low SIR score, reducing the average human
viruses SIR score. Thus the proper analysis is the case-by-case
comparison of similar viruses, as was done in the herpes, HIV and
HBV cases.
3.4 Early versus late viral proteins
The selection against viral epitopes does not end at the full virus
level. Not all viral proteins are subject to the same immune pressure.
An example from a different branch of the immune system would be
the gp120 in HIV and Hemaglutinin in Inﬂuenza. These proteins are
underthemoststringentpressurefromBcells,sincetheyaredirectly
accessible to antibodies. Similarly one could assume that different
viralproteinsareundermoreorlessimmunepressurefromCTL.We
hypothesized that early proteins should express less epitopes than
late proteins. Such a difference is expected, since viruses probably
attempt to delay as much as possible the destruction of infected cells
to ensure the probability of budding before cellular destruction.
We have compared early to late proteins in 24 different viruses,
mostlyAdenoviruses, Herpes viruses and HPV. In most HLAalleles
tested the average SIR score ratio of late to early proteins is higher
than one. This result is valid for most viruses, as well as for
the average of all viruses (All positive values in Fig. 4 represent
allele/viruscombinationwithahigherepitopedensityinlateproteins
thaninearlyproteins).Thedifferencebetweenearlyandlateproteins
is signiﬁcant, when comparing the average SIR over all alleles
(t-test, P 0.0001), or when the SIR for each allele is taken into
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Fig. 4. SIR score of early versus late proteins. The data is shown for 24
viruses of all candidates HLA alleles (31 alleles). Each column represents
the ratio between the difference of the late and early SIR score to their sum
([SIR(late)−SIR(early)]/[SIR(late)+SIR(early)]).FormostHLA\virusthe
ratio is more than 0, indicating a signiﬁcant positive difference in the number
of presented epitopes between these groups.
account (Anova, P< 1.e–100). Thus quite systematically, late viral
proteins express more epitopes than early ones. Assuming, viruses
would make all possible efforts to evade detection, one could
assume that viruses would remove all epitopes through mutations.
However, given the large number of epitopes resulting from the
MHC polymorphism and the probable cost of mutations, viruses are
probably limited in their attempts to reduce epitopes. Given these
restrictions, our results show that most of the effort is targeted to
early proteins that are probably the most dangerous for the virus.
Note that the observed effect is the average over a large number
of proteins. At the single protein, many factors can affect the SIR
score. For example, we have shown that proteins down-regulating
MHCpresentationhaveahighSIRscore,whilecriticallatentHerpes
proteins have a very low SIR score (Vider-Shalit et al., 2007).
To summarize, the SIR score of a protein is affected at the most
general level by its amino-acid distribution. At the next level, it is
affected by the type of the virus and the protein expression time in
the viral life cycle and ﬁnally by speciﬁc properties of the protein.
To that one must add a very strong random element resulting from
viral mutations that did not pass selection (such as mutations not
affecting epitopes in the speciﬁc host MHC allele.).
4 DISCUSSION
The precision of CD8+ T-cell epitope presentation and processing
algorithmshasreachedthelevelallowingasystematicanalysisofthe
detailed epitope repertoire of a given organism. We have combined
such algorithms and the large amount of available viral genomic
data to produce for the ﬁrst time a systemic analysis of viral epitope
repertoires.
Viruses and the immune system play an intricate evolutionary
game. Viruses attempt to evade immune detection, while the human
populationisconstantlydrivenbyviralepidemicstouseHLAalleles
presenting viral epitopes. Viruses use a large variety of immune
evasion mechanisms, such as (among other): down-regulation of
MHC-I expression (Hilleman, 2004), self mimicry (Alcami, 2003),
down-regulationofCD1dsurfaceexpression(Yuanet al.,2006)and
mutation of T-cell epitopes (Bowen and Walker, 2005; McMichael
and Phillips, 1997). If the selective pressure affecting viruses and
the immune system was balanced, the epitope density of viruses and
of random sequences should be similar.
We have measured this epitope density and shown that MHC
molecules are actually selected to present more viral epitopes than
human epitopes. This selection is based on the typical amino-
acid usage of viruses, since a random amino-acid sequence with
a distribution resembling the viral amino-acid distribution has the
highest epitope density among all cases studied here. Viruses in
generalattempttoavoidthisbiasbymutatingepitopes.However,not
all viral proteins have the same epitope density. We have deﬁned a
normalizedscoretocomparetheepitopedensityofdifferentviruses.
In a given protein/genome, libraries of all presented epitopes were
devised. These libraries’ size was compared to the size of their
counterpart in a random sequence of similar length and amino-acid
distribution. The size ratio was named the SIR score.
The SIR score of all human viruses was found to be lower than
the one of non-human viruses. Note that highly acute viruses, such
as ebola and smallpox had a SIR score higher than 1. A reduction
in the number of presented epitopes can have crucial effects on
the immune response, since the average number of epitopes is of
the order of one per protein per HLA (Louzoun et al., 2006). A
reduction in this number can simply prevent the immune detection
of a given protein. A single epitope could theoretically induce an
immune response. Thus theoretically, as long as the SIR score is not
0, an immune response is possible. However, the immune response
is a stochastic process. The viral effort to reduce the epitope number
accompanied by other immune evasion methods are probably meant
to reduce the probability that an infected cell should be destroyed to
a level allowing some of the infected cell to produce virions. Even
if most cells are indeed destroyed, a few surviving infected cells can
be enough to ensure a successful infection.
Even within a given virus, not all proteins have the same SIR
score.Wecomparedearlytolateproteinsin24virusesandfoundthat
proteins expressed early in the viral life cycle had a lower SIR score
than late proteins. An early presentation of epitopes may give the
immune system enough time to kill the infected cell before budding,
whilealatedestructionmaynotpreventbuddingandtheinfectionof
new cells. The difference between early and late proteins disappears
when looking at the non-human counterparts of the viruses checked.
The different SIR score seems to directly result from the negative
selection of epitopes in the appropriate host. We have compared in a
few viruses the effect of the protein concentration on the SIR score,
but never found a consistent relation. The lack of such a correlation
may stem from the small number of epitopes required to induce an
immune response.
The SIR score has beyond its explanatory power, important
applications. The detection of outliers in the distribution allows us
to detect proteins that the virus tries to ‘hide’ from the immune
system. Their epitopes are optimal targets for immunotherapy or
simply for vaccination. One can assume that if viruses attempt to
hide a protein from the immune system, the detection of this protein
would maximize the immune impact. Thus, the SIR score can track
the important proteins for immunotherapy even if their function is
not known. It can be used for any virus. The full list of epitopes
for other viruses for any HLA alleles can be obtained from the
PEPTIBASE server at peptibase.cs.biu.ac.il.
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